Neuberger Berman Group’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-175,000
| Closed | -$14.5M | – | 1622 |
|
|
2020
Q1 | $14.5M | Sell |
175,000
-18,600
| -10% | -$1.54M | 0.02% | 573 |
|
|
2019
Q4 | $21.5M | Sell |
193,600
-6,400
| -3% | -$711K | 0.03% | 581 |
|
|
2019
Q3 | $19.8M | Sell |
200,000
-30,000
| -13% | -$2.98M | 0.02% | 579 |
|
|
2019
Q2 | $22.8M | Sell |
230,000
-24,000
| -9% | -$2.38M | 0.03% | 566 |
|
|
2019
Q1 | $28M | Sell |
254,000
-1,000
| -0.4% | -$110K | 0.03% | 517 |
|
|
2018
Q4 | $23.5M | Hold |
255,000
| – | – | 0.03% | 518 |
|
|
2018
Q3 | $28.1M | Sell |
255,000
-1,100
| -0.4% | -$121K | 0.03% | 544 |
|
|
2018
Q2 | $23.9M | Sell |
256,100
-17,900
| -7% | -$1.67M | 0.03% | 598 |
|
|
2018
Q1 | $22.7M | Sell |
274,000
-2,300
| -0.8% | -$191K | 0.03% | 605 |
|
|
2017
Q4 | $25.2M | Buy |
276,300
+30,589
| +12% | +$2.79M | 0.03% | 576 |
|
|
2017
Q3 | $18.7M | Buy |
245,711
+237,055
| +2,739% | +$18.1M | 0.02% | 627 |
|
|
2017
Q2 | $649K | Sell |
8,656
-18,492
| -68% | -$1.39M | ﹤0.01% | 1242 |
|
|
2017
Q1 | $1.77M | Buy |
27,148
+11,483
| +73% | +$749K | ﹤0.01% | 1021 |
|
|
2016
Q4 | $863K | Buy |
+15,665
| New | +$863K | ﹤0.01% | 1163 |
|
|
2016
Q3 | – | Sell |
-48,053
| Closed | -$2.01M | – | 1642 |
|
|
2016
Q2 | $2.01M | Sell |
48,053
-54,058
| -53% | -$2.26M | ﹤0.01% | 974 |
|
|
2016
Q1 | $4.37M | Buy |
102,111
+45,817
| +81% | +$1.96M | 0.01% | 868 |
|
|
2015
Q4 | $2.55M | Buy |
+56,294
| New | +$2.55M | ﹤0.01% | 969 |
|